NCT02595684View on ClinicalTrials.gov

Effect of Tadalafil on Insulin Secretion and Insulin Sensitivity in Obese Men.

PHASE4CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Obesity
Interventions
DRUG

Tadalafil

Tadalafil capsules: 5 mg, one per day, at night, during 28 days.

DRUG

Placebo

Calcined magnesia capsules: one per day, at night, during 28 days.

Trial Locations (1)

44140

Instituto de Terapéutica Experimental y Clínica, Guadalajara

All Listed Sponsors
lead

University of Guadalajara

OTHER

NCT02595684 - Effect of Tadalafil on Insulin Secretion and Insulin Sensitivity in Obese Men. | Biotech Hunter | Biotech Hunter